Phio Pharmaceuticals Corp.
(NASDAQ : PHIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -3.06%181.120.0%$879.59m
AMGNAmgen, Inc. -0.50%245.011.5%$589.04m
NVAXNovavax, Inc. -4.68%57.4575.7%$440.21m
VRTXVertex Pharmaceuticals, Inc. 1.03%291.001.9%$424.20m
GILDGilead Sciences, Inc. -0.36%60.871.0%$370.94m
REGNRegeneron Pharmaceuticals, Inc. 1.02%619.892.6%$347.97m
SNSSSunesis Pharmaceuticals, Inc. 4.65%4.050.7%$283.11m
ILMNIllumina, Inc. 0.58%225.073.3%$242.93m
BIIBBiogen, Inc. 0.14%218.511.8%$201.51m
GOVXGeoVax Labs, Inc. -4.13%3.090.0%$153.94m
BNTXBioNTech SE -9.68%165.390.0%$138.47m
CRSPCRISPR Therapeutics AG 0.39%81.720.6%$133.29m
RYTMRhythm Pharmaceuticals, Inc. 11.81%22.630.0%$102.07m
MRTXMirati Therapeutics, Inc. 7.34%92.911.6%$100.38m
BMRNBioMarin Pharmaceutical, Inc. 1.04%96.824.2%$96.33m

Company Profile

Phio Pharmaceuticals Corp. is a biotechnology company engaged in the development of immuno-oncology therapeutics that addresses unmet medical needs. Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.